Hologic stock heads into the open after a 2.1 percent drop

Hologic stock closed at USD 76.07 on the Nasdaq on September 8, 2026, falling 2.1% from the prior session’s close in a modest pullback near recent highs. Per Nasdaq data cited by MarketBeat, this closing level was close to the stock’s 52-week high of USD 76.07, underscoring how the decline came after a strong run in recent weeks.

September 8, 2026 in numbers

Hologic Inc. (ISIN US4364401012, Nasdaq: HOLX) ended trading on September 8, 2026 at USD 76.07 on the Nasdaq, down 2.1% from the previous close, according to quote data referenced by Ad-hoc-news. The same report notes that trading volume on the day was broadly in line with Hologic’s typical daily turnover, suggesting no extreme positioning by investors into the close. According to the overview at MarketBeat, the 52-week range for the shares currently runs from USD 51.90 to USD 76.07, so the latest close leaves the stock right at its documented 52-week high. With the Nasdaq Composite index reported lower by around 0.3% on September 8, 2026, as detailed in a market wrap from Yahoo Finance, Hologic’s 2.1% decline represented a larger move than the broader tech-heavy benchmark on the same session.

Today’s focus for Hologic stock

Into today’s US session on September 10, 2026, investors in Hologic are watching the stock after it recently touched the top of its 52-week range, as highlighted by the quote statistics at MarketBeat. No major company-specific events such as an earnings release or annual meeting are recorded for Hologic today in the latest earnings and corporate calendars referenced by external data providers, so the stock is likely to trade primarily on broader sector sentiment and any new healthcare or technology index moves during the session. Broader US equity performance, including the path of the Nasdaq Composite and other benchmarks following their recent mild decline, may therefore provide important context for how Hologic shares behave once the opening bell rings.